Chugai Pharmaceutical Co. is not in talks to become a wholly owned unit of Roche Holdings AG, contrary to a recent report about a $10 billion (¥1.02 trillion) share deal linked to the matter, the Tokyo-based drugmaker said.
“Chugai is in no way in the process of reviewing any plan to become a wholly owned subsidiary of Roche, nor discussing” such a transaction, Chugai said in a statement Saturday.
Bloomberg News reported Friday that the Swiss drugmaker, which holds a 61.5 percent stake in Chugai, is in talks to buy the remaining shares of the Japanese subsidiary, with the deal possibly to be announced in a week, citing people familiar with the negotiation.
“Roche, as usual, is not commenting on market rumors,” Chugai said.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.